Equally, potent pre-clinical activity of CD33-specific CAR-T cells displayed in a xenograft leukemia model coincided with pronounced cytopenias emanating from on-target/off-leukemia toxicity against myeloid progenitors [85]. The gene discussed is CD33; the disease is leukemia.